Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Urokinase Plasminogen Activator | 7 | 2019 | 41 | 1.110 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2018 | 97 | 0.540 |
Why?
|
| Proteinuria | 3 | 2018 | 81 | 0.330 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2014 | 33 | 0.320 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2018 | 44 | 0.310 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 50 | 0.300 |
Why?
|
| Thrombosis | 2 | 2018 | 59 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2018 | 73 | 0.260 |
Why?
|
| Podocytes | 3 | 2019 | 85 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 34 | 0.210 |
Why?
|
| Atrial Appendage | 2 | 2018 | 45 | 0.190 |
Why?
|
| Firearms | 1 | 2019 | 1 | 0.180 |
Why?
|
| Civil Rights | 1 | 2019 | 3 | 0.180 |
Why?
|
| Social Control, Formal | 1 | 2019 | 4 | 0.180 |
Why?
|
| Ownership | 1 | 2019 | 6 | 0.180 |
Why?
|
| Coronary Thrombosis | 1 | 2019 | 6 | 0.170 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 12 | 0.170 |
Why?
|
| Plasma Exchange | 1 | 2018 | 15 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 44 | 0.170 |
Why?
|
| Image Enhancement | 1 | 2018 | 57 | 0.170 |
Why?
|
| Vascular Calcification | 1 | 2018 | 11 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 90 | 0.160 |
Why?
|
| Contrast Media | 1 | 2018 | 125 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2019 | 115 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 125 | 0.150 |
Why?
|
| Apolipoproteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2014 | 40 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2019 | 140 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 28 | 0.150 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 21 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2016 | 16 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 123 | 0.140 |
Why?
|
| Hospitalization | 1 | 2019 | 317 | 0.140 |
Why?
|
| Male | 11 | 2021 | 15637 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 200 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 172 | 0.130 |
Why?
|
| Female | 11 | 2021 | 16211 | 0.130 |
Why?
|
| Cicatrix | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2014 | 14 | 0.120 |
Why?
|
| Middle Aged | 8 | 2019 | 9823 | 0.120 |
Why?
|
| Humans | 14 | 2021 | 29361 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2018 | 1812 | 0.110 |
Why?
|
| Risk Factors | 4 | 2021 | 2446 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 29 | 0.110 |
Why?
|
| Thrombectomy | 1 | 2012 | 27 | 0.110 |
Why?
|
| Aged | 7 | 2019 | 9447 | 0.100 |
Why?
|
| Biomarkers | 3 | 2018 | 692 | 0.090 |
Why?
|
| Mice | 3 | 2019 | 1620 | 0.080 |
Why?
|
| Apolipoprotein L1 | 2 | 2018 | 8 | 0.080 |
Why?
|
| Heart Failure | 1 | 2011 | 204 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 250 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2019 | 3273 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 726 | 0.060 |
Why?
|
| Animals | 3 | 2019 | 4577 | 0.060 |
Why?
|
| United States | 2 | 2021 | 2332 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3476 | 0.050 |
Why?
|
| Transplantation, Autologous | 2 | 2012 | 195 | 0.050 |
Why?
|
| Adolescent | 2 | 2017 | 2280 | 0.050 |
Why?
|
| Adult | 3 | 2019 | 8604 | 0.050 |
Why?
|
| Sex Factors | 1 | 2021 | 496 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 18 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 10 | 0.040 |
Why?
|
| Adipocytes | 1 | 2019 | 11 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 18 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 70 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 53 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2018 | 6 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 70 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2019 | 46 | 0.040 |
Why?
|
| Rituximab | 1 | 2018 | 53 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2018 | 39 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 234 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 24 | 0.040 |
Why?
|
| Echocardiography | 1 | 2019 | 171 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2019 | 170 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2018 | 91 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 350 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 24 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 7 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 125 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2016 | 55 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 224 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 57 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 44 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 161 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 54 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 521 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2019 | 483 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 788 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 405 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 304 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 840 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 678 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 441 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 788 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 770 | 0.030 |
Why?
|
| Muscle Development | 1 | 2014 | 4 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 56 | 0.030 |
Why?
|
| Tomography, Spiral Computed | 1 | 2014 | 26 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2014 | 56 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1618 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1220 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1345 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 4 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2012 | 17 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1829 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1939 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 277 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 9 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 17 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1935 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 503 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4851 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 664 | 0.020 |
Why?
|